1-6 of 6
Hiroshi Yamaguchi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Role of the DNA Damage Checkpoint Pathway in Intraductal Papillary Mucinous Neoplasms of the Pancreas

Yoshihiro Miyasaka, Eishi Nagai, Hiroshi Yamaguchi, Kei Fujii, Takahiro Inoue, Kenoki Ohuchida, Tomomi Yamada, Kazuhiro Mizumoto, Masao Tanaka, Masazumi Tsuneyoshi
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4371–4377.
https://doi.org/10.1158/1078-0432.CCR-07-0032
Published: 01 August 2007
View article titled, The Role of the DNA Damage Checkpoint Pathway in Intraductal Papillary Mucinous Neoplasms of the Pancreas
Open the PDF for The Role of the DNA Damage Checkpoint Pathway in Intraductal Papillary Mucinous Neoplasms of the Pancreas in another window
Journal Articles

S100P Is an Early Developmental Marker of Pancreatic Carcinogenesis

Kenoki Ohuchida, Kazuhiro Mizumoto, Takuya Egami, Hiroshi Yamaguchi, Kei Fujii, Hiroyuki Konomi, Eishi Nagai, Koji Yamaguchi, Masazumi Tsuneyoshi, Masao Tanaka
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (18): 5411–5416.
https://doi.org/10.1158/1078-0432.CCR-06-0298
Published: 25 September 2006
View article titled, <em>S100P</em> Is an Early Developmental Marker of Pancreatic Carcinogenesis
Open the PDF for <em>S100P</em> Is an Early Developmental Marker of Pancreatic Carcinogenesis in another window
Journal Articles

S100A11, A Putative Tumor Suppressor Gene, Is Overexpressed in Pancreatic Carcinogenesis

Kenoki Ohuchida, Kazuhiro Mizumoto, Seiji Ohhashi, Hiroshi Yamaguchi, Hiroyuki Konomi, Eishi Nagai, Koji Yamaguchi, Masazumi Tsuneyoshi, Masao Tanaka
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (18): 5417–5422.
https://doi.org/10.1158/1078-0432.CCR-06-0222
Published: 25 September 2006
View article titled, <em>S100A11</em>, A Putative Tumor Suppressor Gene, Is Overexpressed in Pancreatic Carcinogenesis
Open the PDF for <em>S100A11</em>, A Putative Tumor Suppressor Gene, Is Overexpressed in Pancreatic Carcinogenesis in another window
Journal Articles

Quantitative Analysis of Human Telomerase Reverse Transcriptase in Pancreatic Cancer

Kenoki Ohuchida, Kazuhiro Mizumoto, Daisuke Yamada, Hiroshi Yamaguchi, Hiroyuki Konomi, Eishi Nagai, Koji Yamaguchi, Masazumi Tsuneyoshi, Masao Tanaka
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (7): 2066–2069.
https://doi.org/10.1158/1078-0432.CCR-05-1821
Published: 11 April 2006
View article titled, Quantitative Analysis of Human Telomerase Reverse Transcriptase in Pancreatic Cancer
Open the PDF for Quantitative Analysis of Human Telomerase Reverse Transcriptase in Pancreatic Cancer in another window
Journal Articles

Identification of HLA-A24-Restricted CTL Epitope from Cancer-Testis Antigen, NY-ESO-1, and Induction of a Specific Antitumor Immune Response

Hiroshi Yamaguchi, Fumiaki Tanaka, Mitsuhiko Ohta, Hiroshi Inoue, Masaki Mori
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (3): 890–896.
https://doi.org/10.1158/1078-0432.CCR-1086-3
Published: 10 February 2004
View article titled, Identification of HLA-A24-Restricted CTL Epitope from Cancer-Testis Antigen, NY-ESO-1, and Induction of a Specific Antitumor Immune Response
Open the PDF for Identification of HLA-A24-Restricted CTL Epitope from Cancer-Testis Antigen, NY-ESO-1, and Induction of a Specific Antitumor Immune Response in another window
Journal Articles

Dendritic Cell Vaccination with MAGE Peptide Is A Novel Therapeutic Approach for Gastrointestinal Carcinomas

Noriaki Sadanaga, Hideki Nagashima, Kohjiro Mashino, Kouichirou Tahara, Hiroshi Yamaguchi, Mitsuhiko Ohta, Tatsuo Fujie, Fumiaki Tanaka, Hiroshi Inoue, Kazutou Takesako, Tsuyoshi Akiyoshi, Masaki Mori
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2277–2284.
Published: 01 August 2001
View article titled, Dendritic Cell Vaccination with MAGE Peptide Is A Novel Therapeutic Approach for Gastrointestinal Carcinomas
Open the PDF for Dendritic Cell Vaccination with MAGE Peptide Is A Novel Therapeutic Approach for Gastrointestinal Carcinomas in another window